Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06087120Recruiting
Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
Breast Cancer FemaleHER2-positive Breast CancerStage II Breast Cancer+2 more
PrincipalinvestigatorStart date: 2023-09-16

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Trung Q Lam, MD

University medical center HCMC

Similar
1 trials

Shared therapeutic areas:

Breast Cancer FemaleHER2-positive Breast CancerStage II Breast Cancer+2 more

Worked with same sponsors:

Gene Solutions
Collaborated on 1 trial
Similarity Score54%

Sinh D Nguyen, PhD

MGI

Similar
2 trials

Shared therapeutic areas:

Breast Cancer FemaleHER2-positive Breast CancerStage II Breast Cancer+2 more

Worked with same sponsors:

Gene Solutions
Collaborated on 1 trial
Similarity Score54%

Mothaffar Rimawi, MD

Baylor College of Medicine

Related
8 trials

Shared therapeutic areas:

Breast Cancer FemaleHER2-positive Breast CancerTriple Negative Breast Neoplasms
Similarity Score18%

Jennifer Ligibel, MD

Dana-Farber Cancer Institute

Related
11 trials

Shared therapeutic areas:

Breast Cancer FemaleStage II Breast CancerStage III Breast Cancer
Similarity Score18%

Jun Mao, MD, MSCE

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

Stage II Breast CancerStage III Breast Cancer
Similarity Score12%

Shari Goldfarb, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

Stage II Breast CancerStage III Breast Cancer
Similarity Score12%

Agustin Garcia, MD

University of Southern California

Related
8 trials

Shared therapeutic areas:

Stage II Breast CancerTriple Negative Breast Neoplasms
Similarity Score12%

Norman Wolmark, MD

NSABP Foundation Inc

Related
54 trials

Shared therapeutic areas:

Stage II Breast CancerTriple Negative Breast Neoplasms
Similarity Score12%

Ingrid Mayer, MD

Vanderbilt-Ingram Cancer Center

Related
13 trials

Shared therapeutic areas:

Stage III Breast Cancer
Similarity Score6%

Kari Wisinski, MD

University of Wisconsin, Madison

Related
7 trials

Shared therapeutic areas:

Triple Negative Breast Neoplasms
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06087120PrincipalInvestigator

Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment

Breast Cancer FemaleHER2-positive Breast CancerStage II Breast Cancer+2 more
Recruiting

All 1 trials loaded